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   SHORT-TERM HEALTH EFFECTS OF 
PARTICULATE AIR POLLUTION WITH 
SPECIAL REFERENCE TO THE NEEDS OF 
SOUTHERN EUROPEAN COUNTRIES
• 
Exposure to air pollution, especially from particulate matter, is generally ac-
cepted to be one of the most important public health problems in Europe and 
worldwide. The effects caused in the general population are associated with 
relatively small relative risks, but if the ubiquity of exposure is considered, the 
attributable number of events is large. Furthermore, there is evidence that the 
effects in sensitive population subgroups (such as the elderly, those with chro-
nic diseases and children) are stronger. Within large European Union funded 
collaborative projects (such as the Air Pollution and Health: a European Ap-
proach - APHEA), effect modification by geographical characteristics has been 
investigated and it was found that in warmer countries, in locations where par-
ticles come from traffic and where the proportion of the elderly is greater, par-
ticle toxicity is increased. These characteristics are particularly relevant to 
Southern European locations. From other projects we know that meteorolo-
gical, climatic, environmental and socioeconomic factors are effect modifiers of 
the effects of specific air pollutants. In this presentation we will show the evi-
dence on the short-term health effects of particulate and gaseous air pollutants 
and emphasize particularly results concerning southern Europe and potential 
effect modifiers. The gaps in knowledge and the need to study air pollution in 
Southern European countries more extensively will be demonstrated. To con-
duct useful research, good quality air pollution and health data are needed. 
Keywords: air pollution; ambient particles; effect modification; Southern 
Europe. 
 
 
The effects of air pollution on health were recog-
nized after severe air pollution episodes in Northern 
Europe and North America between 1900 and 1965, 
to which thousands of acute deaths have been 
attributed [1]. These events led to a reduction of air 
pollution levels through legislative and other measu-
res. From about 1970 to 1990, the prevailing opinion 
among scientists and decision makers was that cur-
rent air pollution levels did not have important ad-
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verse health effects. However, since roughly 1990, it 
became evident that the current, relatively lower, air 
pollution levels (mainly ambient particles) had ad-
verse, short-term and long-term, health effects includ-
ing an increase in mortality. The initial evidence ori-
ginated from short-term exposure epidemiological 
studies [2,3]. As it accumulated, it had a considerable 
impact in standard setting and proposed guidelines 
for air pollutants by National (such as the U.S. Envi-
ronmental Protection Agency) [4] and International 
(such as the World Health Organization and the Euro-
pean Commission) [5,6] organizations. As a result, in 
EU there is a requirement for frequent monitoring of 
specific air pollutants and a good spatial coverage 
leading to several well conducted and informative stu-
dies [7]. The problem of health effects from exposure 
to air pollutants is more important in southern and 
central-eastern EU and non-EU countries of Europe, K. KATSOUYANNI: SHORT-TERM HEALTH EFFECTS OF PARTICULATE AIR POLLUTION…  CI&CEQ 18 (4) 675−679 (2012) 
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as the concentrations of pollutants have often been 
measured at higher levels and the particles mixtures 
have been found more toxic in warmer countries, 
either because of particular characteristics of the par-
ticles or due to larger population exposures [5,8-12]. 
However, in some countries there is still a lack of sys-
tematic measurements covering adequately the time 
and spatial scale. 
The effects of air pollution on health are often 
conveniently classified as short-term and long-term 
although there is probably a continuum of effects in 
the time scale, which are not yet fully understood. By 
“short-term” effects we usually refer to the effects 
manifested in the same or the next few days (e.g. up 
to a week) after a specific exposure to an air pollutant 
or a mixture of air pollutants and, in recent studies, 
also to the effects over a period of about 30-40 days. 
By “long-term” effects we refer to effects resulting 
from a life-long exposure or, at least, one over a long 
period of several years.  
This paper will emphasize the results of short-
term studies. 
SHORT-TERM EFFECTS OF PARTICULATE AIR 
POLLUTION ON HEALTH 
Short-term effects are studied through, mainly, 
two epidemiological study designs:  
1. Time series studies, which use aggregated 
data and the unit of aggregation is a time period, 
usually of a day. These data are often routinely col-
lected and are available for long time periods. One 
advantage of the design is that there is no confound-
ing by individual characteristics. However, there is po-
tential confounding by variables that vary on daily 
basis (e.g., temperature).  
2. Panel studies, which are based on a cohort 
followed intensively for a relatively short time. These 
studies often have daily individual data [13].  
3. More recently, the case-crossover analysis is 
also used. In this approach, days with an event are 
compared to days without the event matched on im-
portant confounders. This approach requires smaller 
data availability and has a wider applicability [14].  
During the last two to three decades a vast 
amount of research has accumulated on the short-
term health effects of particulate matter (PM). PM 
metrics used in most studies are based on mass con-
centrations with size cut-offs (e.g., PM10, PM2.5, PM1). 
Less research has focused on the sources and spe-
cific chemical characteristics of PM, although these 
have considerable significance because there is evi-
dence that the toxicity of PM depends on their chemi-
cal-physical characteristics and, consequently, on 
their sources [5,15]. 
PM is deposited in various parts of the respi-
ratory system mainly depending on their size. Mecha-
nisms of toxicity have been described in the toxico-
logical literature including inflammation and immuno-
logical responses. The outcomes assessed in epide-
miological studies range from the least severe sub-
clinical effects to moderate ones, like impaired pulmo-
nary function, respiratory symptoms, excess medica-
tion use, restricted activity and visits to medical doc-
tors and finally to more severe, like emergency room 
visits or hospital admissions and premature deaths [5]. 
Mortality outcomes 
During the late 80’s and early 90’s several time-
series studies produced evidence of short-term ef-
fects of exposure to PM on the daily number of deaths. 
Their results were put in a broader context and were 
consolidated with the initiation of large multi-city stu-
dies in Europe and the U.S. In 1993 the multi-city Eu-
ropean Commission sponsored APHEA (“Air Pollution 
and Health: a European Approach”) project was ini-
tiated [16]. It included data from up to 30 European 
cities spanning across the continent.  An increase of 
10 μg m
-3 in PM10 was found to be associated with a 
0.6% increase in the total and respiratory daily num-
ber of deaths and a 0.8% increase in cardiovascular 
deaths [17]. When a longer time period after the ex-
posure is considered (about 40 days) then the ob-
served increase in total mortality is estimated to be 
1.6%; in cardiovascular mortality 1.97% and in respi-
ratory mortality 4.2%, indicating lagged effects, which 
are larger for respiratory deaths [18]. The NMMAPS 
(“National Mortality, Morbidity and Air Pollution Stu-
dy”) in the U.S. reported consistent results [19].  
The shape of the exposure-response relation-
ship is important for public health assessment, as this 
reveals the possible existence of a safe level and the 
effect size at specific ranges of the pollutants concen-
trations. It has been found that the exposure-res-
ponse is compatible with a straight line and there is 
no identifiable threshold within the range of concen-
trations observed in the European and North Ameri-
can cities [20]. 
The public health importance of the short-term 
mortality effects has often been questioned. The cri-
tics suggested that only the very frail individuals, who 
were going to die soon, could be affected by air pol-
lution exposure. However, if this “harvesting” hypo-
thesis were true, the observed increase in mortality 
would have been followed by a subsequent decrease 
of equal size. The use of analyses with distributed lag 
models gave evidence that this does not happen, i.e., K. KATSOUYANNI: SHORT-TERM HEALTH EFFECTS OF PARTICULATE AIR POLLUTION…  CI&CEQ 18 (4) 675−679 (2012) 
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for about 40 days after exposure, mortality remains 
elevated [21]. 
The city specific effect estimates of the above 
multi-city studies often displayed heterogeneity. In-
vestigating the reasons for heterogeneity, effect mo-
difiers were identified, within the context of the Eu-
ropean–North American collaboration, the APHENA 
project. It was found that in cities with higher propor-
tion of elderly and lower socio-economic status the ef-
fect of PM10 on mortality is higher. In Europe there 
was evidence that in cities in which the NO2 levels 
were higher, PM effects were larger. As NO2 is consi-
dered a marker of traffic related pollution, this finding 
may indicate that particles are more harmful in cities 
where the source of PM is to a larger extent the traf-
fic. Also in Europe but not in North America it was 
found that in warmer cities the effects of PM were 
larger. This latter finding may be indicative of the fact 
that in warmer European cities (where the prevalence 
of air conditioning is lower compared to warmer U.S. 
cities) the population is more exposed to outdoor air 
pollution, or, alternatively, that the mixture of PM is 
more toxic [22].  
There is evidence that apart from the elderly, 
other sub-groups are particularly sensitive to the ef-
fects of ambient particles. Thus in the HEAPSS (Health 
Effects of Air Pollution  on Susceptible Subpopula-
tions) multi-center European project it was found that 
that in myocardial infarction (MI) survivors there is a 
5.1% increase in the risk of dying after an increase of  
10 μg m
-3 in PM10 (compared with 0.6% in the general 
population) [23]. Thus, it is accepted that the elderly 
and those with chronic cardiovascular or respiratory 
conditions form particularly sensitive sub-groups with 
respect to air pollution effects.  
Considering the size distribution of PM, there is 
some evidence of an association of PM2,5 with respi-
ratory and cardiovascular mortality and of the coarse 
fraction especially with respiratory deaths, from stu-
dies done in specific locations. A study attempting to 
explain the heterogeneity among mortality effects in 
60 of the NMMAPS cities, identified higher effect esti-
mates in cities with higher Nickel and Vanadium [24]. 
Morbidity outcomes 
From the APHEA study results, the increase of 
10 μg m
-3 in PM10 is associated with an increase of 
about 1% in asthma admissions among children and 
in respiratory and COPD admissions among the el-
derly [25]. Also there is an increase in cardiac admis-
sions, more pronounced in the elderly, and especially 
those for ischaemic heart disease (IHD) [25]. In the 
NMMAPS study, an increase of 1.2% was found for 
cardiac admissions and 2% for respiratory admissions 
after 2 days exposure to increased PM10 by 10 μg m
-3 
[19]. Several other studies have reported analogous 
results for respiratory and cardiovascular hospital 
admissions and emergency department visits. 
Among MI survivors, from the HEAPSS study 
results, there is a 2.1% increase in the risk of being 
admitted in hospital after an increase of 10 μg m
-3 in 
PM10, indicating that persons suffering a previous MI 
are more sensitive to PM10 effects [27]. Results from 
another multi-center study (AIRGENE) indicate that 
one possible mechanism for acute effects is through 
increased inflammation, as IL-6 and fibrinogen were 
found to increase after exposure of MI survivors to 
higher ambient PM10 concentrations [28]. From panel 
studies done mainly in children with respiratory symp-
toms or diagnosed asthma, a decrease of lung func-
tion parameters and an increase of medication use 
and symptoms have been reported [7]. 
NOVEL DESIGNS AND FUTURE PATHWAYS OF 
RESEARCH 
In recent years, there has been significant inte-
rest in better assessing the effects of particle com-
ponents and particle sources. Several studies re-
ported that PM originating from traffic is more toxic 
compared to that from other sources [29,30]. Particles 
from other sources, such as long-range transport of 
Sahara dust and forest fires have been evaluated [31- 
–33]. Some short-term studies have reported results 
on particle components. Zanobetti et al. reported 
higher effects of fine PM with metal compounds as 
well as organic carbon on hospital admissions [34]. 
Atkinson  et al. reported that ultrafine particles are 
more important for cardiovascular health, whilst se-
condary pollutants (especially nitrate and sulfate) are 
more important for respiratory admissions [35]. Ostro 
et al. found increased effects for traffic PM, sulfates 
and PM from construction dust in Barcelona [36]. Mo-
dels based on GIS systems provided more indivi-
dualized exposure estimates on the spatial scale and 
recent developments complement this by adding a 
fine time scale [37]. Emphasis is put on sensitive sub-
groups and gene-environment interactions [28]. 
THE IMPORTANCE OF RESEARCH IN SOUTHERN 
EUROPE 
The evidence on geographical heterogeneity of 
PM toxicity and the identified importance of sources, 
highlights the significance of local studies on the ef-
fects of PM. Especially the finding that PM are, for the 
same concentration levels, more toxic in warmer ci-
ties, is particularly relevant for Southern Europe. This K. KATSOUYANNI: SHORT-TERM HEALTH EFFECTS OF PARTICULATE AIR POLLUTION…  CI&CEQ 18 (4) 675−679 (2012) 
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fact may be due to the specific physical and chemical 
characteristics of the PM mixture or to the patterns of 
population exposure (i.e., people may spend more 
time outdoors in warmer climates). Further research 
on the role of specific PM characteristics and on the 
population time-activity patterns is needed.  
In order to have an adequate number of good 
quality studies in all European countries, the main 
prerequisite is good quality data. Exposure data can 
be routinely collected for short-term health effect stu-
dies and require a good system of continuously ope-
rating fixed site monitors. High time and spatial reso-
lution is necessary. Furthermore, the need for com-
plete registration of health outcome data (especially 
morbidity, since mortality is fully registered) should 
not be underestimated.  
In less developed European economies, the 
sources of PM are abundant and not well regulated: 
the vehicle fleets tend to be older, the quality of the 
fuel is sub-optimal, traffic is more dense and “clean” 
public transportation more restricted. There is there-
fore an urgent need to obtain better data, apply local 
studies, inform the population, as well as the decision 
makers. Short-term effect studies, which have been 
pioneers in the past, can offer a relatively cheap, easy 
and efficient way of assessing health effects of PM 
and other pollutants. 
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STRUČNI RAD 
   KRAKTOTRAJNI ZDRAVSTVENI EFEKTI USLED 
IZLOŽENOSTI RESPIRABILNIM ČESTICAMA SA 
OSVRTOM NA POTREBE ISTRAŽIVANJA U 
ZEMLJAMA JUŽNE EVROPE 
Opšte je prihvaćeno da je zagađenje vazduha, posebno respirabilnim česticama, jedan 
od najvažnijih problema javnog zdravlja i u Evropi i na svetu. Iako je relativno mali rizik 
od zdravstvenih efekta po opštu populaciju, ako se utvrdi opšte prisutna izloženost, pri-
pisuje se i veći broj događaja. Štaviše, postoji dokaz da uticaj veći kod osetljive grupe 
populacije ko što su stariji, oni sa hroničnim bolestima, i deca. U okviru velikih projekta, 
kao što je Aerozagađenje i zdravlje: evropski pristup - APHEA, ispitivan je uticaj geo-
grafskih karakterisitka na promenu efekata i utvrđeno je da je toksičnost čestica pove-
ćana u toplijim zemljama, na lokcijama gde su prisutne čestice poreklom od saobraćaja i 
gde je procenat starijih veliki. Ove karakteristike su posebno značajne na lokacijama 
Južne Evrope. Na osnovu rezultata niza projekta utvrđeno je da meteorološki, klimatski, 
uslovi životne sredine i socioekonomski faktori deluju na promenu zdravstvenih efekata 
specifičnih aerozagađivača. U ovom radu mi ćemo evidentirati kratkotrajne zdravstvene 
efekte aerozagađivača u vidu čestica i gasova i posebno istaći rezultate koji se odnose 
na južnu Evropu i potencijalne promene efekata. Biće pokazane praznine u poznavanju i 
potreba za intenzivnije proučavanje aerozagađenja u zemljama Južne Evrope. Za spro-
vođenje korisnih istraživanja potrebni su kvalitetni podaci o aerozagađenju i zdravstve-
nim efektima. 
Ključne reči: aerozagađenje, respirabilne čestice u ambijentu, efekti promena, 
Južna Evropa. 
 
 